Media Summary: In this dynamic panel from the 2023 CGT Summit hosted by Charles River Laboratories, experts from Charles River, Vernal ... Nicola Maciocia, MBChB, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses ... Currently approved chimeric antigen receptor (
Advancing Car T Therapy Manufacturing Analytics Allogeneic Platforms - Detailed Analysis & Overview
In this dynamic panel from the 2023 CGT Summit hosted by Charles River Laboratories, experts from Charles River, Vernal ... Nicola Maciocia, MBChB, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses ... Currently approved chimeric antigen receptor ( Learn more about the CliniMACS Prodigy ... This panel from the 2024 CGT Summit hosted by Charles River Laboratories brings together experts from Outpace Bio, Moonlight ... This video provides a comprehensive overview of the
Bruce Levine, PhD, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, discusses the key remaining ... Cancer affects about 20 million of people worldwide every year, driving science to develop Only a handful of US research labs have the ability to make cancer immunotherapies, called Claire Roddie, MD, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses the University ... Expert panelists move beyond clinical trial data to discuss real-world applications of chimeric antigen receptor (
